Clinical exploration of using a multidisciplinary collaborative diagnosis and treatment system to treat menopausal psychosomatic disorders in women

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500102297

Enrollment

Unknown

Registered

2025-05-13

Start date

2025-05-16

Completion date

Unknown

Last updated

2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal psychosomatic disorders (MPSD)

Interventions

Observation group:Exposure to psychological and social factors

Eligibility

Sex/Gender

Female

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Women in perimenopause and within 6 years after menopause. 2. Complies with MPSD diagnosis. 3. Informed consent, voluntary testing.

Exclusion criteria

Exclusion criteria: 1. Individuals with mental illnesses; 2. Those who suffer from diseases caused by risk factors such as infection, transmission, chemical (radiation and drug poisoning, etc.); 3. Individuals with organic diseases such as hyperthyroidism, cardiovascular and urogenital systems; 4. Individuals taking Hormones or other medications.

Design outcomes

Primary

Measure	Time frame
Clinical efficacy;	—

Countries

China

Contacts

Public ContactZhang Jianping

Debao County Maternal and Child Health Hospital

328218167@qq.com+86 776 382 2834

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026